Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q84623804)
Watch
English
With maturity comes confidence: EBCTCG tamoxifen update
scientific article published on 28 July 2011
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21802719
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21802719%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 February 2020
title
With maturity comes confidence: EBCTCG tamoxifen update
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21802719
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21802719%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 February 2020
main subject
tamoxifen
1 reference
based on heuristic
inferred from title
author
Antonio C. Wolff
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21802719
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21802719%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 February 2020
author name string
Stephen K Chia
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21802719
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21802719%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 February 2020
language of work or name
English
0 references
publication date
28 July 2011
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21802719
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21802719%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 February 2020
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21802719
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21802719%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 February 2020
volume
378
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21802719
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21802719%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 February 2020
issue
9793
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21802719
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21802719%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 February 2020
page(s)
747-749
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21802719
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21802719%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 February 2020
cites work
Global cancer statistics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961128-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961128-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961128-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961128-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term benefits of 5 years of tamoxifen: 10-year follow-up of a large randomized trial in women at least 50 years of age with early breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961128-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Coronary heart disease mortality after 5 years of adjuvant tamoxifen therapy: results from a randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961128-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Estrogen receptor: a never ending story?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961128-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961128-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961128-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961128-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961128-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961128-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(11)61128-8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21802719
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21802719%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 February 2020
PubMed publication ID
21802719
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21802719
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21802719%20AND%20SRC:MED&resulttype=core&format=json
retrieved
9 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
